Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-24-071418
Filing Date
2024-08-21
Accepted
2024-08-21 15:13:11
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q ea0211019-10qa_bioess.htm   iXBRL 10-Q/A 615352
2 CERTIFICATIONS ea021101903ex31-1_bioess.htm EX-31.1 22790
3 CERTIFICATIONS ea021101903ex32-1_bioess.htm EX-32.1 12644
4 GRAPHIC image_001.jpg GRAPHIC 7168
  Complete submission text file 0001213900-24-071418.txt   4766523

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bioe-20240630.xsd EX-101.SCH 59471
6 XBRL CALCULATION FILE bioe-20240630_cal.xml EX-101.CAL 51344
7 XBRL DEFINITION FILE bioe-20240630_def.xml EX-101.DEF 244513
8 XBRL LABEL FILE bioe-20240630_lab.xml EX-101.LAB 441655
9 XBRL PRESENTATION FILE bioe-20240630_pre.xml EX-101.PRE 239594
81 EXTRACTED XBRL INSTANCE DOCUMENT ea0211019-10qa_bioess_htm.xml XML 463597
Mailing Address 12 CHRYSLER UNIT B IRVINE CA 92618
Business Address 12 CHRYSLER UNIT B IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

EIN.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-56263 | Film No.: 241228587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)